TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 95 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,014,000 | -52.6% | 160,908 | -46.4% | 0.14% | -55.4% |
| Q2 2017 | $2,139,000 | -22.4% | 300,000 | 0.0% | 0.31% | -29.7% |
| Q1 2017 | $2,757,000 | +128.0% | 300,000 | 0.0% | 0.44% | +88.4% |
| Q4 2016 | $1,209,000 | -99.9% | 300,000 | 0.0% | 0.23% | +27.5% |
| Q3 2016 | $1,149,000,000 | +88969.8% | 300,000 | 0.0% | 0.18% | -20.5% |
| Q2 2016 | $1,290,000 | -7.1% | 300,000 | 0.0% | 0.23% | -17.0% |
| Q1 2016 | $1,389,000 | -38.5% | 300,000 | +33.3% | 0.28% | -19.1% |
| Q4 2015 | $2,257,000 | +34.4% | 225,000 | 0.0% | 0.34% | +27.2% |
| Q3 2015 | $1,679,000 | -67.0% | 225,000 | +109.5% | 0.27% | -56.2% |
| Q2 2015 | $5,095,000 | +14.0% | 107,400 | -12.0% | 0.61% | -18.8% |
| Q1 2015 | $4,470,000 | – | 122,000 | – | 0.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |